E3810
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for E3810, covering 2011-06-17 to 2018-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients [Phase 3]